Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherRevenue - Other
Ratios

Nuvation Bio (NUVB) R&D In Process (2024)

Nuvation Bio (NUVB) has disclosed R&D In Process for 1 consecutive years, with $425.1 million as the latest value for Q2 2024.

  • On a quarterly basis, R&D In Process changed N/A to $425.1 million in Q2 2024 year-over-year; TTM through Sep 2025 was $425.1 million, a 0.0% change, with the full-year FY2024 number at $425.1 million, changed N/A from a year prior.
  • R&D In Process was $425.1 million for Q2 2024 at Nuvation Bio.
  • In the past five years, R&D In Process ranged from a high of $425.1 million in Q2 2024 to a low of $425.1 million in Q2 2024.